AC
AMGN icon

AlphaCore Capital’s Amgen AMGN Stock Holding History

AlphaCore Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.93M Buy
16,842
+2,203
+15% +$785K 0.14% 131
2025
Q4 		$4.79M Buy
14,639
+4,818
+49% +$1.53M 0.11% 167
2025
Q3 		$2.77M Sell
9,821
-1,547
-14% -$449K 0.09% 167
2025
Q2 		$3.17M Buy
11,368
+2,633
+30% +$746K 0.12% 133
2025
Q1 		$2.72M Buy
8,735
+4,534
+108% +$1.34M 0.23% 92
2024
Q4 		$1.09M Buy
4,201
+195
+5% +$57.9K 0.24% 72
2024
Q3 		$1.29M Buy
4,006
+470
+13% +$154K 0.29% 63
2024
Q2 		$1.1M Buy
3,536
+2,471
+232% +$726K 0.27% 65
2024
Q1 		$303K Buy
+1,065
New +$312K 0.08% 126
2020
Q2 		– Sell
-45
Closed -$9K – 82
2020
Q1 		$9K Buy
+45
New +$9.83K 0.01% 220

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

AlphaCore Capital's AMGN Position: Q1 2026 in Review

AlphaCore Capital increased its Amgen (AMGN) stake by 15% in Q1 2026, buying an estimated $785K and bringing the position to 16,842 shares worth $5.93M. The position accounts for 0.14% of the portfolio, ranked #131.

AlphaCore Capital first reported a position in AMGN in Q1 2020 and has held it in 10 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • AlphaCore Capital held 16,842 shares of Amgen worth $5.93M as of Q1 2026.
  • AlphaCore Capital bought 2,203 Amgen shares in Q1 2026, an estimated $785K.
  • Amgen made up 0.14% of AlphaCore Capital's portfolio in Q1 2026, its #131 holding.
  • AlphaCore Capital first reported a position in Amgen in Q1 2020 and has held it in 10 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on AlphaCore Capital's 13F filing for Q1 2026, filed 15 May 2026.